In conclusion, our study provides compelling evidence that JT can mitigate renal fibrosis and improve renal function in a CKD model through mechanisms involving the SIRT3/P53 signaling pathway and the inhibition of ferroptosis. The gene discussed is SIRT3; the disease is renal fibrosis.